Delivery Order SPE2DB20D2014-SPE2DB25FC72H
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $74,819.21 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed-price contract. This non-set-aside award, issued on August 13, 2025, requires completion by August 14, 2025, with performance to be executed in Conshohocken, Pennsylvania. The delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,495.60 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,037.52 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed-price contract. The award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $6,535.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on July 18, 2025, with an ultimate completion date of July 21, 2025. This delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $105,401.40 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 Syringe 0.5ML, a pneumococcal vaccine product. The contract, awarded on July 25, 2025, carries a firm fixed price and is scheduled for ultimate completion by July 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,151.86 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5ML) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was awarded without set-aside designation through open competition and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $6,337.95 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5 mL syringe format. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at $81,411.49 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed price contract. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $27,844.80 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 6, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $19,229.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5ML syringes under contract number 4568915768. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order issued under the company's larger Indefinite Delivery Contract...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC72HDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,812.31 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5 mL) under a firm fixed-price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026 that enables the supplier to furnish a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability to meet DLA requirements through competitive awards, delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for PREVNAR 20 pneumococcal vaccine reflects the company's role in supporting the Defense Health Agency and other government healthcare systems through flexible contract vehicles designed to ensure consistent availability of essential medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 8/12/25 |